Skip to main content

Table 4 Indications for bronchoscopy in post-acute phase according to hospital admission during the acute infection

From: Bronchoscopy in the post-acute phase of COVID-19: an observational study

 

Indication for bronchoscopy

Non-Hospitalized in the acute phase (n = 16)

Hospitalized in the acute phase (n = 29)

p-value

Bronchoscopy 1

Suspected tracheal stenosis

1 (6.3)

4 (13.8)

0.44

Therapeutic management of tracheal stenosis

0 (0.0)

2 (6.9)

0.28

Follow-up of a known tracheal stenosis/tracheostomy complication (e.g., granuloma)

0 (0.0)

8 (27.6)

0.02

Tracheal complications (all previous together)

1 (6.3)

14 (48.3)

0.007

Assistance during decannulation

0 (0.0)

1 (6.3)

0.17

Haemoptysis

1 (6.3)

0 (0.0)

0.17

Persistent parenchymal infiltrates at chest imaging

9 (56.3)

5 (17.2)

0.008

Suspected late infection

2 (12.5)

6 (20.7)

0.49

Obstructive atelectasis

1 (6.3)

2 (6.9)

0.94

Presence of lymphadenopathies at CT scan

1 (6.3)

1 (3.5)

0.66

Bronchoscopy 2

Therapeutic management of tracheal stenosis

0/1 (0.0)

2/10 (20.0)

 

Follow-up of a known tracheal stenosis/tracheostomy complication (e.g., granuloma)

1/1 (100.0)

4/10 (40.0)

 

Persistent parenchymal infiltrates at chest imaging

0/1 (0.0)

2/10 (20.0)

 

Obstructive atelectasis

0/1 (0.0)

1/10 (10.0)

 

Occurrence of lymphadenopathies at CT scan

0/1 (0.0)

1/10 (10.0)

 

Bronchoscopy 3

Follow-up of a known tracheal stenosis/tracheostomy complication (e.g., granuloma)

-

1/2 (50.0)

 

Suspected late infection

-

1/2 (50.0)

 
  1. CT: computed tomography